Leadless cardiac pacing: What primary care providers and non-EP cardiologists should know

Area of Science:

• Cardiology
• Medical Devices
• Biomedical Engineering

Background:

• Transvenous pacemakers have been used for 50 years but are associated with long-term complications in over 10% of patients, primarily due to endovascular leads and surgical pockets.
• These complications include issues related to the pacemaker pocket and limitations on patient mobility.

Purpose of the Study:

• To introduce leadless cardiac pacing as a novel solution to the limitations of transvenous pacemakers.
• To highlight the advantages of leadless pacing, including the elimination of pocket-related complications and improved post-procedural patient mobility.
• To discuss the current limitations and future potential of leadless pacing technology.

Main Methods:

• Leadless cardiac pacing involves the percutaneous deployment of a self-contained pacemaker directly into the heart, obviating the need for transvenous leads and a surgical pocket.
• The study reviews existing literature and clinical outcomes associated with leadless pacing devices.

Main Results:

• Leadless pacing eliminates pocket-related complications common with transvenous systems.
• Patients experience enhanced shoulder mobility and can resume daily activities like driving and bathing sooner.
• Current leadless devices are limited to single-chamber ventricular pacing.

Conclusions:

• Leadless cardiac pacing represents a significant advancement, mitigating major complications associated with traditional pacemakers.
• Future developments are expected to enable dual-chamber and atrial pacing, as well as integration with subcutaneous defibrillators for comprehensive cardiac rhythm management.
• This technology promises improved patient quality of life and expanded therapeutic options for bradycardia and potentially other arrhythmias.